An investigationThis report is the product of a journalistic investigation on clinical trials. It set out to identify ethical concerns in clinical trials that were conducted in India and used for approval of new drugs in the European Union (EU). It was initiated after discussions with the health advocacy organisation Wemos and the research organisation Centre for Research on Multinational Corporations (SOMO), both based in Amsterdam. Wemos has been campaigning with EU regulatory authorities to prevent the use of unethically conducted clinical trials towards marketing approval in the EU. The plan was to document available information on up to three trials and the ethical concerns that they raised. read more less
The European Alliance for Responsible Research & Development and Affordable Medicines (of which SOMO is a member) wrote a letter to the European Commission to express our concern about the next EU Health Private-Public Partnership….
In this joint statement, several civil society organisations have expressed their major concerns about the role of supplementary protection certificates (SPCs) in the accessibility and price of medicines in the Netherlands and elsewhere in Europe….
In the run-up to the general debate on Medicines policy on Thursday June 21st 2018, eight organizations in the Netherlands jointly sent a letter to the Dutch Parliament to inform them abouth their position concerning…